Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 4
1986 1
1987 11
1988 5
1989 6
1990 3
1991 3
1992 3
1993 3
1994 8
1995 8
1996 10
1997 7
1998 18
1999 25
2000 40
2001 74
2002 72
2003 76
2004 62
2005 98
2006 111
2007 116
2008 120
2009 162
2010 201
2011 257
2012 265
2013 288
2014 302
2015 345
2016 314
2017 336
2018 311
2019 381
2020 385
2021 472
2022 336
2023 350
2024 350
2025 346
2026 179

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,753 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Rhee H, Kim MJ, Kim DY. Rhee H, et al. Among authors: kim dy. Gastroenterology. 2025 Nov;169(6):1319-1320. doi: 10.1053/j.gastro.2025.07.025. Epub 2025 Jul 23. Gastroenterology. 2025. PMID: 40712933 No abstract available.
Molecular hallmarks of excitatory and inhibitory neuronal resilience to Alzheimer's disease.
Castanho I, Naderi Yeganeh P, Boix CA, Morgan SL, Mathys H, Prokopenko D, White B, Soto LM, Pegoraro G, Shah S, Ploumakis A, Kalavros N, Bennett DA, Lange C, Kim DY, Bertram L, Tsai LH, Kellis M, Tanzi RE, Hide W. Castanho I, et al. Among authors: kim dy. Mol Neurodegener. 2025 Oct 1;20(1):103. doi: 10.1186/s13024-025-00892-3. Mol Neurodegener. 2025. PMID: 41035073 Free PMC article.
Clinical Practice Guidelines for Diagnosis and Non-Surgical Treatment of Primary Frozen Shoulder.
Lee BC, Kim BS, Lee BJ, Moon CW, Park CH, Kim DH, Yun DH, Park D, Kim DY, Kim DH, Kim GW, Kim HJ, Jung IY, Kim IJ, Park JH, Lee JH, Ahn J, Lim JY, Yoon JA, Lee JH, Hwang JM, Kim K, Uhm KE, Choi KH, Nam KE, Min K, Chang MC, Park MW, Kim N, Park HK, Kim SH, Yang S, Won SJ, Moon SG, Chung SJ, Jee S, Lee WH, Park YB, Na Y, Won YH, Im YJ, Yoon YS, Lee YJ, Soh Y, Han JY. Lee BC, et al. Among authors: kim dy. Ann Rehabil Med. 2025 Jun;49(3):113-138. doi: 10.5535/arm.250057. Epub 2025 Jun 30. Ann Rehabil Med. 2025. PMID: 40602400 Free PMC article.
Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008.
Ryu SY, Deng W, Albuquerque K, Koh WJ, Mayadev J, Heugel A, Kim BJ, Kim DY, Cho CH, Kim JW, No JH, Mannel RS, Miller K, Fabian D, Chase DM, Gil KM, Small W Jr, Rodgers W, Leath CA 3rd, Monk BJ. Ryu SY, et al. Among authors: kim dy. Ann Oncol. 2025 Dec;36(12):1514-1524. doi: 10.1016/j.annonc.2025.09.003. Epub 2025 Sep 12. Ann Oncol. 2025. PMID: 40947016 Free PMC article. Clinical Trial.
A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.
Feldman HH, Cummings JL, Boxer AL, Staffaroni AM, Knopman DS, Sukoff Rizzo SJ, Territo PR, Arnold SE, Ballard C, Beher D, Boeve BF, Dacks PA, Diaz K, Ewen C, Fiske B, Gonzalez MI, Harris GA, Hoffman BJ, Martinez TN, McDade E, Nisenbaum LK, Palma JA, Quintana M, Rabinovici GD, Rohrer JD, Rosen HJ, Troyer MD, Kim DY, Tanzi RE, Zetterberg H, Ziogas NK, May PC, Rommel A. Feldman HH, et al. Among authors: kim dy. Alzheimers Dement. 2024 Nov;20(11):8129-8152. doi: 10.1002/alz.14250. Epub 2024 Sep 24. Alzheimers Dement. 2024. PMID: 39316411 Free PMC article. Review.
Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.
HCMR Investigators; Kramer CM, Kolm P, DiMarco JP, Desai MY, Ho CY, Kwong RY, Dolman SF, Desvigne-Nickens P, Geller N, Kim DY, Schulz-Menger J, Friedrich MG, Maron MS, Appelbaum E, Link MS, Francis GS, Greenberg B, Jerosch-Herold M, Piechnik S, Mahmod M, Raman B, Jacoby DL, Baldassare LA, White JA, Chiribiri A, Helms AS, Choudhury L, Michels M, Bradlow WM, Salerno M, Heitner SB, Masri A, Prasad SK, Mohiddin SA, Plein S, Madias C, Mahrholdt H, Bucciarelli-Ducci C, Nightingale AK, Weinsaft JW, Kim HW, McCann GP, van Rossum A, Germans T, Williamson EE, Geske JB, Flett AS, Dawson D, Mongeon FP, Olivotto I, Crean AM, Woo A, Owens AT, Anderson L, Sharma S, Biagini E, Newby DE, Andre F, Berry C, Kim B, Larose E, Abraham TP, Hays AG, Sherrid MV, Gelfand EV, Nagueh SF, Rimoldi O, Camici P, Elstein E, Autore C, Watkins H, Weintraub WS, Neubauer S. HCMR Investigators, et al. Among authors: kim dy. JAMA. 2026 Jun 9;335(22):1959-1969. doi: 10.1001/jama.2026.5633. JAMA. 2026. PMID: 42113540
Lipid-Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-Blind, Parallel, Multicenter, Phase 3 Clinical Trial.
Ki YJ, Kim W, Lee KH, Han SJ, Kim YH, Doh JH, Kim TN, Chung CH, Kim DY, Cho JM, Yoon HJ, Jeong IK, Park S, Song KH, Yu CW, Cho DK, Choi SH, Oh SJ, Shin S, Jeong H, Park Y, Kim HS. Ki YJ, et al. Among authors: kim dy. Clin Cardiol. 2025 May;48(5):e70138. doi: 10.1002/clc.70138. Clin Cardiol. 2025. PMID: 40357888 Free PMC article. Clinical Trial.
5,753 results